290 related articles for article (PubMed ID: 27193166)
21. SOX9, through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates BEST1 expression in the retinal pigment epithelium.
Masuda T; Esumi N
J Biol Chem; 2010 Aug; 285(35):26933-26944. PubMed ID: 20530484
[TBL] [Abstract][Full Text] [Related]
22. Suppression of Ca2+ signaling in a mouse model of Best disease.
Zhang Y; Stanton JB; Wu J; Yu K; Hartzell HC; Peachey NS; Marmorstein LY; Marmorstein AD
Hum Mol Genet; 2010 Mar; 19(6):1108-18. PubMed ID: 20053664
[TBL] [Abstract][Full Text] [Related]
23. The role of bestrophin-1 in intracellular Ca(2+) signaling.
Strauß O; Müller C; Reichhart N; Tamm ER; Gomez NM
Adv Exp Med Biol; 2014; 801():113-9. PubMed ID: 24664688
[TBL] [Abstract][Full Text] [Related]
24. Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy.
Sinha D; Steyer B; Shahi PK; Mueller KP; Valiauga R; Edwards KL; Bacig C; Steltzer SS; Srinivasan S; Abdeen A; Cory E; Periyasamy V; Siahpirani AF; Stone EM; Tucker BA; Roy S; Pattnaik BR; Saha K; Gamm DM
Am J Hum Genet; 2020 Aug; 107(2):278-292. PubMed ID: 32707085
[TBL] [Abstract][Full Text] [Related]
25. BEST1: the Best Target for Gene and Cell Therapies.
Yang T; Justus S; Li Y; Tsang SH
Mol Ther; 2015 Dec; 23(12):1805-9. PubMed ID: 26388462
[TBL] [Abstract][Full Text] [Related]
26. Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors.
Zhang K; Liu GH; Yi F; Montserrat N; Hishida T; Esteban CR; Izpisua Belmonte JC
Protein Cell; 2014 Jan; 5(1):48-58. PubMed ID: 24474194
[TBL] [Abstract][Full Text] [Related]
27. Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies.
Nachtigal AL; Milenkovic A; Brandl C; Schulz HL; Duerr LMJ; Lang GE; Reiff C; Herrmann P; Kellner U; Weber BHF
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111077
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Ca
Cordes M; Bucichowski P; Alfaar AS; Tsang SH; Almedawar S; Reichhart N; Strauß O
FASEB J; 2020 Mar; 34(3):4055-4071. PubMed ID: 31930599
[TBL] [Abstract][Full Text] [Related]
29. Differentiation, Maintenance, and Analysis of Human Retinal Pigment Epithelium Cells: A Disease-in-a-dish Model for BEST1 Mutations.
Kittredge A; Ji C; Zhang Y; Yang T
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30199040
[TBL] [Abstract][Full Text] [Related]
30. Screening of BEST1 Gene in a Chinese Cohort With Best Vitelliform Macular Dystrophy or Autosomal Recessive Bestrophinopathy.
Tian L; Sun T; Xu K; Zhang X; Peng X; Li Y
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3366-3375. PubMed ID: 28687848
[TBL] [Abstract][Full Text] [Related]
31. A Novel BEST1 Mutation in Autosomal Recessive Bestrophinopathy.
Lee CS; Jun I; Choi SI; Lee JH; Lee MG; Lee SC; Kim EK
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8141-50. PubMed ID: 26720466
[TBL] [Abstract][Full Text] [Related]
32. Distinct expression requirements and rescue strategies for
Zhao Q; Kong Y; Kittredge A; Li Y; Shen Y; Zhang Y; Tsang SH; Yang T
Elife; 2021 Jun; 10():. PubMed ID: 34061021
[TBL] [Abstract][Full Text] [Related]
33. Tadalafil Rescues the p.M325T Mutant of Best1 Chloride Channel.
Elverson K; Warwicker J; Freeman S; Manson F
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110551
[TBL] [Abstract][Full Text] [Related]
34. Novel and homozygous BEST1 mutations in Chinese patients with Best vitelliform macular dystrophy.
Wong RL; Hou P; Choy KW; Chiang SW; Tam PO; Li H; Chan WM; Lam DS; Pang CP; Lai TY
Retina; 2010 May; 30(5):820-7. PubMed ID: 20057343
[TBL] [Abstract][Full Text] [Related]
35. Mutant Best1 Expression and Impaired Phagocytosis in an iPSC Model of Autosomal Recessive Bestrophinopathy.
Marmorstein AD; Johnson AA; Bachman LA; Andrews-Pfannkoch C; Knudsen T; Gilles BJ; Hill M; Gandhi JK; Marmorstein LY; Pulido JS
Sci Rep; 2018 Mar; 8(1):4487. PubMed ID: 29540715
[TBL] [Abstract][Full Text] [Related]
36. Functional roles of bestrophins in ocular epithelia.
Marmorstein AD; Cross HE; Peachey NS
Prog Retin Eye Res; 2009 May; 28(3):206-26. PubMed ID: 19398034
[TBL] [Abstract][Full Text] [Related]
37. Investigation and Restoration of BEST1 Activity in Patient-derived RPEs with Dominant Mutations.
Ji C; Li Y; Kittredge A; Hopiavuori A; Ward N; Yao P; Fukuda Y; Zhang Y; Tsang SH; Yang T
Sci Rep; 2019 Dec; 9(1):19026. PubMed ID: 31836750
[TBL] [Abstract][Full Text] [Related]
38. The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene.
Querques G; Zerbib J; Santacroce R; Margaglione M; Delphin N; Querques L; Rozet JM; Kaplan J; Souied EH
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4678-84. PubMed ID: 21436265
[TBL] [Abstract][Full Text] [Related]
39. Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutations.
Kamata K; Otsuka Y; Imamura K; Oishi A; Kondo T; Suga M; Shibukawa R; Okanishi Y; Sagara Y; Tsukita K; Yasukawa T; Usui H; Muguruma K; Tsujikawa A; Inoue H
Stem Cell Res; 2020 May; 45():101782. PubMed ID: 32416576
[TBL] [Abstract][Full Text] [Related]
40. A novel compound heterozygous mutation in the BEST1 gene causes autosomal recessive Best vitelliform macular dystrophy.
Zhao L; Grob S; Corey R; Krupa M; Luo J; Du H; Lee C; Hughes G; Lee J; Quach J; Zhu J; Shaw PX; Kozak I; Zhang K
Eye (Lond); 2012 Jun; 26(6):866-71. PubMed ID: 22422030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
